World Stroke Organization 
;
#MondayTip
From WSO/ICAA-A Cerebral Amyloid Angiopathy Statement
π―Management of antithrombotics in #CAA requires individualized, risk-balanced decision-making, given CAAβs intrinsically high risk of ICH
Phenotypic markers by @a_charidimou
Statement: https://doi.org/10.1177/17474930251365861
πWebinar on #StrokeSpasticity Management, Dec 11th, 3pm (CET)
π©βπ»Topics include global impact, optimizing #botulinumtoxin therapy & exploring #telerehabilitation to enhance recovery & patient outcomes
ποΈππππππππ: https://us02web.zoom.us/webinar/register/WN_gMpCwNTPSMWLKPkwSoKYFw#/registration
#StrokeEducation @Bayer
π΄We are #live! Join experts Ellis van Etten, @a_charidimou, David Werring and @SMGreenbergNeur to learn more about the diagnosis and management of #CerebralAmyloidAngiopathy (CAA).
πππππππ πππ: https://us02web.zoom.us/webinar/register/WN_z_OuKtEJQSui8CWbhP17cA#/
@WorldStrokeOrg @IntJStroke #StrokeEducation
What happened in #StrokeEducation in November? Time to read our newsletter!
ποΈhttps://www.world-stroke-academy.org/news/november-newsletter-2/
π’Webinars
π’PoM: Pre-Hospital Care w/ @IntJStroke
π’WSC2025 TV Studio w/ @OruenCNS
π’Meet The Trialist w/ @Bayer
π’#MondayTips by @interneurona
πππ©π©π² ππππ«π§π’π§π !
